Arzanya

Macrocyclic peptide discovery

A deep-tech technology platform for the generation, quantitative screening and fine characterization of tailored macrocyclic peptide ligands.

OUR MISSION

Accelerating novel therapeutics discovery

ARZANYA

Our mission is to advance next-generation therapies through an innovative combinatorial platform designed to discover macrocyclic peptide ligands for a wide range of therapeutic applications. 

our technology

Bridging the gap: innovative
solutions for complex therapeutic
challenges

TEAM & SAB

Global expertise, deep-rooted scientific vision.

Our foundation is built upon the world’s leading research corridors. By combining the technical mastery of our PhD co-founders with the strategic oversight of a Scientific Advisory Board composed of industry pioneers, we bridge the gap between complex biomolecular engineering and next-generation therapeutic solutions.

00
PhD-Led Leadership
00
Years of Combined R&D Experience
00
World-Class Institutions
Network

Academic partnerships

our science

Discover our publications and news